QuantiFERON-TB gold test for screening latent tuberculosis infection in hemodialysis patients;Hemodiyaliz hastalarında latent tüberküloz infeksiyonu taramasında quantiferon-tb gold test

Tuberkuloz ve Toraks

Volumn 59, Issue 2, 2011, Pages 105-110

  Sayarlioǧlu, Hayriye ^a   Gül, Mustafa ^a   Eren Daǧli, Canan ^a   Doǧan, Ekrem ^a   Şahin, Murat ^a   Uçar, Mehmet Ali ^a   Köksal, Nurhan ^a   Sayarlioǧlu, Mehmet ^a   Tahta, Mümtaz Kerim ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b Kahramanmaras State Hospital   (Turkey)

Author keywords

Hemodialysis patient; Latent tuberculosis infection; QuantiFERON TB gold test; Tuberculin skin test

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL EVALUATION; DEMOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; LABORATORY TEST; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; SCREENING TEST; SKIN INDURATION; THORAX RADIOGRAPHY; TUBERCULIN TEST; VACCINATION;

EID: 79961095190     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: 10.5578/tt.2353     Document Type: Article

References (19)

1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: (Suppl 1): S221-S247.
2. Hussein MM, Mooij MJ, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003; 16: 38-44.
3. Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and aner-gy skin testing of patients receiving long-term hemodialysis. Chest 1998; 113: 25-7.
4. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille-Calmette-Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-9.
5. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-76.
6. Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, et al. Interferon-gamma release assays for diagnosing myco-bacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008; 3: 1357-63.
7. Özkara Ş, Aktaş Z, Özkan S, Ecevit H. Türkiye'de Tüberkülo-zun Kontrolü İçin Başvuru Kitabi{dotless}. Ankara: Saǧli{dotless}k Bakanli{dotless}ǧi{dotless} Verem Savaşi{dotless} Daire Başkanli{dotless}ǧi{dotless}, 2003: 9-10.
8. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gar-dam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT. TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2006;2:68-73.
9. Wauters A, Peetermans WE, Van den Brande P, De Moor B, Evenepoel P, Keuleers H, et al. The value of tuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 2004;19: 433-8.
10. Choudhury D, Salazar CL. Preventive health care in chronic kidney disease and end-stage renal disease. Nat Clin Pract Nephrol 2008; 4: 194-206.
11. Farhat M, Greenaway C, Pai M, Menzies D. False positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuber Lung Dis 2006; 10: 1192-204.
12. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170: 65-9.
13. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7: 77.
14. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic ha-emodialysis patients. Nephrol Dial Transplant 2009; 24: 1952-6.
15. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of Qu-antiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009; 37: 96-102.
16. Cengiz K. Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron 1996; 73: 421-4.
17. Rutsky EA, Rostand SG. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med 1980; 140: 57-61.
18. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immuno-compromised patients. Eur Respir J 2007; 30: 945-50.
19. IInoue T, Nakamura T, Katsuma A, Masumoto S, Minami E, Katagiri D, et al. The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant 2009; 24: 2252-7.